Outflow Tract Calcification and the Best Valve in This Context

Moderate or severe left ventricle outflow tract calcification increases the risk of annulus rupture, residual aortic regurgitation and the need for a second valve. This recent study analyzed the performance of different contemporary prosthetic valves in patients with this particular anatomy. 

Calcificación del tracto de salida

Since the early days of transcatheter aortic valve replacement (TAVR) outflow tract calcification has been associated to adverse events. In addition, the evidence available was limited to a modest number of observational studies, incomplete followup and the lack of study of the difference devices. 

Moderate or severe calcification was considered with at least 2 nodules, or one extending over 5 mm, or covering over 10% of the outflow tract perimeter.

Of 1635 patients undergoing TAVR, moderate to severe calcification of the outflow tract was documented in nearly 25% of patients (407 patients, 24.9%).

These patients showed a significantly higher risk of annulus rupture (2.3% vs 0.2%; p<0.001), the need for a second valve (2.9% vs 0.8%; p=0.004) and residual aortic failure (11.1% vs. 6.3%; p=0.002).


Read also: ESC 2020 | Ticagrelor Might Increase Bleeding and Mortality in the Elderly.


The balloon expandable valve showed higher risk of annulus rupture in these patients (4.0% vs. 0.4%; p=0.002) vs all the self-expandable valves.

The need for a second valve and residual regurgitation resulted similar across device range. 

Conclusion

Outflow tract calcification increases the risk of annulus rupture, residual aortic regurgitation and the need for a second valve. Annulus rupture resulted far more frequent with the balloon expandable valve, while the rest of complications resulted similar across devices. 

Título original: Impact of Left Ventricular Outflow Tract Calcification on Procedural Outcomes After Transcatheter Aortic Valve Replacement.

Referencia: Taishi Okuno et al. J Am Coll Cardiol Intv 2020;13:1789–99. https://doi.org/10.1016/j.jcin.2020.04.015.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...

Cardiac Remodeling After Percutaneous ASD Closure: Should It Be Immediate or Progressive?

Atrial septal defect (ASD) is a common congenital heart disease that generates a left-to-right shunt, leading to right-side chamber overload and a risk of...

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...